Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Pharmacokinetics and Pharmacodynamics|November 16, 2010
Two bootstrapping routines for obtaining imprecision estimates for nonparametric parameter distributions in nonlinear mixed effects modelsPaul G Baverel, Radojka M Savic, Mats O KarlssonContemporary Clinical Trials Communications|February 24, 2022
Exposure driven dose escalation design with overdose control: Concept and first real life experience in an oncology phase I trialSandrine Micallef, Alexandre Sostelly, Jiawen Zhu, et al.Clinical Pharmacology and Therapeutics|August 1, 2017
Dose-Exposure-Response Relationship of the Investigational Anti-Interleukin-13 Monoclonal Antibody Tralokinumab in Patients With Severe, Uncontrolled AsthmaPaul G Baverel, Nicholas White, Paolo Vicini, et al.Journal of Pharmacokinetics and Pharmacodynamics|July 3, 2009
Evaluation of the nonparametric estimation method in NONMEM VI: application to real dataPaul G Baverel, Radojka M Savic, Justin J Wilkins, et al.British Journal of Clinical Pharmacology|July 18, 2015
Pharmacokinetics of tralokinumab in adolescents with asthma: implications for future dosingPaul G Baverel, Meena Jain, Iwona Stelmach, et al.The Journal of Allergy and Clinical Immunology|June 20, 2013
Pharmacodynamic modeling of cough responses to capsaicin inhalation calls into question the utility of the C5 end pointEmma C Y Hilton, Paul G Baverel, Ashley Woodcock, et al.CPT: Pharmacometrics & Systems Pharmacology|January 19, 2021
Early predictions of response and survival from a tumor dynamics model in patients with recurrent, metastatic head and neck squamous cell carcinoma treated with immunotherapyIgnacio González-García, Vadryn Pierre, Vincent F S Dubois, et al.Pharmaceutics|April 30, 2021
Pharmacokinetic-Pharmacodynamic Modelling of Systemic IL13 Blockade by Monoclonal Antibody Therapy: A Free Assay Disguised as TotalJohn Hood, Ignacio González-García, Nicholas White, et al.CPT: Pharmacometrics & Systems Pharmacology|August 16, 2021
Step-by-step comparison of ordinary differential equation and agent-based approaches to pharmacokinetic-pharmacodynamic modelsVan Thuy Truong, Paul G Baverel, Grant D Lythe, et al.Oncoimmunology|April 2, 2021
Association of circulating protein biomarkers with clinical outcomes of durvalumab in head and neck squamous cell carcinomaRosalinda Arends, Xiang Guo, Paul G Baverel, et al.Pageof 2